Benitec Biopharma, Inc. (BNTC)
12.72
+0.04
(+0.35%)
USD |
NASDAQ |
Sep 08, 16:00
12.73
0.00 (0.00%)
Pre-Market: 20:00
Benitec Biopharma Total Assets (Quarterly) : 187.00M for March 31, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 187.00M |
| December 31, 2025 | 190.68M |
| September 30, 2025 | 96.03M |
| June 30, 2025 | 99.59M |
| March 31, 2025 | 105.21M |
| December 31, 2024 | 79.07M |
| September 30, 2024 | 68.77M |
| June 30, 2024 | 52.21M |
| March 31, 2024 | 15.00M |
| December 31, 2023 | 21.35M |
| September 30, 2023 | 27.05M |
| June 30, 2023 | 4.464M |
| March 31, 2023 | 8.22M |
| December 31, 2022 | 11.90M |
| September 30, 2022 | 18.12M |
| June 30, 2022 | 5.973M |
| March 31, 2022 | 10.06M |
| December 31, 2021 | 14.01M |
| September 30, 2021 | 17.84M |
| June 30, 2021 | 21.38M |
| March 31, 2021 | 13.43M |
| Date | Value |
|---|---|
| December 31, 2020 | 15.51M |
| September 30, 2020 | 8.916M |
| June 30, 2020 | |
| March 31, 2020 | 13.58M |
| December 31, 2019 | |
| September 30, 2019 | |
| June 30, 2019 | 19.24M |
| March 31, 2019 | |
| December 31, 2018 | |
| September 30, 2018 | |
| June 30, 2018 | |
| March 31, 2018 | |
| December 31, 2017 | |
| September 30, 2017 | |
| June 30, 2017 | |
| March 31, 2017 | |
| December 31, 2016 | |
| September 30, 2016 | 15.84M |
| June 30, 2016 | |
| March 31, 2016 | 20.82M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.743B |
| Alnylam Pharmaceuticals, Inc. | 5.559B |
| Anika Therapeutics, Inc. | 183.47M |
| Savara, Inc. | 192.14M |
| Vericel Corp. | 502.87M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 3.668M |
| Shareholders Equity (Quarterly) | 183.33M |
| Debt to Equity Ratio | 0.0048 |
| Current Ratio | 56.82 |
| Net Debt Paydown Yield | -0.04% |